Showing results (981-990 of 1,763) with videos related to
Sort By:
Pageof 177
The Journal of Laryngology and Otology|September 14, 2022
The effects of surface electrical stimulation plus voice therapy in Parkinson's diseaseM R A van Hooren, L W J Baijens, R Dijkman, et al.Frontiers in Molecular Biosciences|September 12, 2022
Using CRISPR/Cas9 genome editing in human iPSCs for deciphering the pathogenicity of a novel <i>CCM1</i> transcription start site deletionRobin A Pilz, Dariush Skowronek, Motaz Hamed, et al.Brazilian Journal of Physical Therapy|April 27, 2017
Construct and discriminant validity of STarT Back Screening Tool - Brazilian versionBruna Pilz, Rodrigo A Vasconcelos, Paulo P Teixeira, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 18, 2023
The Landscape of Lyme Borreliosis Surveillance in EuropeArchana Nagarajan, Jozica Skufca, Andrew Vyse, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2011
Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodiesG Pilz, A Harrer, K Oppermann, et al.International Journal of Surgery (London, England)|June 6, 2025
Robotic versus laparoscopic liver resection: a systematic review and meta-analysis of comparative studiesGabriela Pilz da Cunha, Tijs J Hoogteijling, Marc G Besselink, et al.Acta Neurologica Scandinavica|September 17, 2013
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?P Wipfler, A Harrer, G Pilz, et al.Anticancer Research|March 16, 2016
Vitamin D and MortalityStefan Pilz, Martin Grübler, Martin Gaksch, et al.Journal of Ophthalmology|May 29, 2014
A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT StudySergio Pagliarini, Stephen Beatty, Blandina Lipkova, et al.Journal of Neurology|August 10, 2012
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosisP Wipfler, A Heikkinen, A Harrer, et al.Pageof 177